Press release
Urokinase Injection Market Dynamics and Key Factors That Will Drive The Market's Growth, Global Opportunity and Industry Forecast 2029 - Valuates Reports
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.The global Urokinase Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Urokinase Injection include NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems Inc and LIVZON, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urokinase Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase Injection.
The Urokinase Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Urokinase Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
Segment by Type
10000-100000IU
100000-1000000IU
Others
Segment by Application
Hospital
Clinic
Others
Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-24O9985/global-urokinase-injection
Similar report -
https://reports.valuates.com/market-reports/QYRE-Auto-4E9798/global-urokinase-for-injection
https://reports.valuates.com/market-reports/GENC-Chem-4J29/titanium-dioxide
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urokinase Injection Market Dynamics and Key Factors That Will Drive The Market's Growth, Global Opportunity and Industry Forecast 2029 - Valuates Reports here
News-ID: 3119245 • Views: …
More Releases from Valuates Reports
Semi-Insulating Silicon Carbide Wafer Market Share Driven by 5G Expansion and Ad …
Semi-Insulating Silicon Carbide Wafer Market Size
The global market for Semi-Insulating Silicon Carbide Wafer was valued at US$ 284 million in the year 2024 and is projected to reach a revised size of US$ 595 million by 2031, growing at a CAGR of 11.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-18Y11148/Global_Semi_Insulating_Silicon_Carbide_Wafer_Market_Research_Report_2022
The Semi-Insulating Silicon Carbide Wafer Market is gaining strong momentum as wide bandgap semiconductor materials become essential to high-frequency, high-power applications in…
4 Inches Semi-Insulating Silicon Carbide Wafer Market Share Driven by Expansion …
4 Inches Semi-Insulating Silicon Carbide Wafer Market Size
The global market for 4 Inches Semi-Insulating Silicon Carbide Wafer was valued at US$ 88.1 million in the year 2024 and is projected to reach a revised size of US$ 155 million by 2031, growing at a CAGR of 8.5% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-35E15164/Global_4_Inches_Semi_Insulating_Silicon_Carbide_Wafer_Market_Research_Report_2023
The 4 Inches Semi-Insulating Silicon Carbide Wafer Market is witnessing growing market size as semiconductor manufacturers increasingly adopt…
300 mm Wafer Front Opening Unified Pod Market Share Driven by Increasing Automat …
300 mm Wafer Front Opening Unified Pod Market
The global market for 300 mm Wafer Front Opening Unified Pod was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-39P12958/Global_300_mm_Wafer_Front_Opening_Unified_Pod_Market_Research_Report_2023
The 300 mm Wafer Front Opening Unified Pod Market is experiencing strong market growth as semiconductor manufacturers prioritize advanced wafer…
Clean Transfer Robot Market Share Driven by Increasing Automation in Semiconduct …
Clean Transfer Robot Market
The global market for Clean Transfer Robot was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-23W12497/Global_Clean_Transfer_Robot_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028
The Clean Transfer Robot Market is witnessing considerable market growth as semiconductor and flat panel display manufacturers adopt advanced robotic handling systems to enhance production reliability, eliminate contamination,…
More Releases for Urokinase
Global Urokinase Market Outlook 2025-2034: Trends, Innovations, And Future Outlo …
The Urokinase Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Urokinase Market Size and Projected Growth Rate?
The urokinase market size will grow from $1.7 billion in 2024 to $1.81 billion in 2025 at a CAGR of 6.0%. The growth in the historic…
Rising Cardiovascular Disease Burden Drives Urokinase Market Growth Driver: Lead …
What market dynamics are playing a key role in accelerating the growth of the urokinase market?
The escalating issue of cardiovascular diseases is projected to augment the expansion of the urokinase market. Cardiovascular diseases (CVDs) encompass a wide array of disorders impacting the heart and blood vessels, including issues like heart attacks, strokes, and hypertension. Higher obesity rates stemming from insufficient physical activity, poor dietary habits, and an aging population are…
Urokinase For Injection Market: A Comprehensive Overview
The global Urokinase For Injection market was valued at approximately USD 141.1 million in 3.5% and is projected to reach around USD 199.0 million by 2033, exhibiting a compound annual growth rate (CAGR) of 3.5% during the forecast period.
Urokinase For Injection Market Overview
Urokinase is a thrombolytic agent used to dissolve blood clots in conditions such as acute myocardial infarction, pulmonary embolism, and deep vein thrombosis. The market's growth…
Urokinase Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
How Big Is the Urokinase Market Expected to Be, and What Will Its Growth Rate Be?
In the previous years, the urokinase market has seen robust growth. The market value is expected to increase from $1.7 billion in 2024 to $1.81 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 6.0%. The historic growth trend can be associated with factors such as the rising number of stroke and heart…
Urokinase Market Set for Exceptional Growth in the Forecast 2025-2032
Latest Market Overview
The global urokinase market is expected to experience significant growth from 2024 to 2032, driven by increasing demand for thrombolytic therapies in various medical applications. As of 2024, the market size is projected to reach USD 2.3 billion and is forecasted to expand at a compound annual growth rate (CAGR) of 7.2% during the forecast period. Urokinase, a protease enzyme primarily used in the treatment of acute myocardial…
Scaling for Success: Latest Research on Global Urokinase Market Expansion and Gr …
Global Urokinase Market Overview:
Global Urokinase Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Urokinase involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry,…
